@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix owl: . @prefix dc: . @prefix xsd: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-GBM73BCQ-W skos:prefLabel "Anti-Bacterial Agents"@en, "Antibactériens"@fr ; a mesh:Descriptor, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-ZLSZT1X2-V skos:prefLabel "beta-Lactams"@en, "bêta-Lactames"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-Z7T9FKFN-2 . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-D4R3T357-5 skos:prefLabel "Sulfures"@fr, "Sulfides"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-Z7T9FKFN-2 . jvr:-Z7T9FKFN-2 skos:hiddenLabel "Ly-127935"@fr, "Ly-127935"@en, "6059S"@fr, "Lilly127935"@fr, "6059-S"@fr, "6059-S"@en, "Lilly 127935"@en, "S-6059"@en, "Disodium Latamoxef"@en, "Lilly-127935"@fr, "Moxalactam Disodium"@en, "1-Oxacephalosporin"@en, "Festamoxin"@en, "Shiomarin"@en, "Ly127935"@fr, "Ly127935"@en, "Disodium Moxalactam"@en ; mesh:allowableQualifier jvr:-FWD2BGQ0-9, jvr:-NKM836P1-M, jvr:-H7K65Q8S-Z, jvr:-BT300B3G-Q, jvr:-G4R176S9-J, jvr:-D0F21513-5, jvr:-WK5F724J-1, jvr:-CB30NGKB-3, jvr:-XV06LPML-W, jvr:-M63HSDM7-1, jvr:-THHNVC7V-3, jvr:-TJHVZCRZ-0, jvr:-T9HQD7ST-J, jvr:-NB0XHT3S-N, jvr:-G30ZJ446-J, jvr:-R3QWLHRG-V, jvr:-NFTHND7Q-8, jvr:-R0ZCQ8X6-J, jvr:-S0CS1X5R-5, jvr:-Q3979798-W, jvr:-W6SQV79N-S, jvr:-SBNWSM1T-R, jvr:-HQRFT0C6-B, jvr:-NHL3D2X0-S, jvr:-L6C0XPHT-4 ; skos:altLabel "VUF6C936Z3"@fr, "VUF6C936Z3"@en, "64952-97-2 (Moxalactam)"@fr, "64952-97-2 (Moxalactam)"@en, "5APW73W3QZ"@fr, "5APW73W3QZ"@en, "Latamoxef"@en, "5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-"@fr, "5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-"@en, "Lamoxactam"@en, "Moxalactam"@fr ; owl:sameAs ; skos:broader jvr:-ZLSZT1X2-V, jvr:-D4R3T357-5 ; dc:created "1983-04-04"^^xsd:date ; skos:prefLabel "Latamoxef"@fr, "Moxalactam"@en ; skos:inScheme jvr: ; a skos:Concept, mesh:Descriptor ; skos:definition "Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections."@en ; mesh:pharmacologicalAction jvr:-GBM73BCQ-W ; dc:established "1984-01-01"^^xsd:date ; dc:modified "2016-05-31"^^xsd:date . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .